Literature DB >> 16772532

Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding Id1 and their functional differentiation through Id2.

Marcin Jankiewicz1, Bernd Groner, Sylvane Desrivières.   

Abstract

Organ development requires the integration of multiple extracellular signals to assure a proper balance between proliferation and differentiation and to achieve and maintain specialized functions. Considerable progress has been made in the study of hormones and growth factors and in the understanding of the regulated intracellular pathways and transcriptional events that contribute to mammogenesis. Cell culture experiments have pointed out crucial pathways and components, which were subsequently validated in vivo experiments. We found that the mammalian target of rapamycin (mTOR) pathway is essential for both growth and differentiation of mammary epithelial cells and that the action of mTOR is mediated through the induction of the helix-loop-helix transcriptional regulators Id1 and Id2. Pharmacological inhibition of mTOR activity in HC11 mammary epithelial cells reduced cellular proliferation and prevented the lactogenic hormone-induced expression of milk proteins. Treatment of female mice with rapamycin impaired mammary gland differentiation and milk protein synthesis. The effects of mTOR on proliferation and differentiation require the functions of the helix-loop-helix proteins Id1 and Id2. Rapamycin treatment of HC11 cells resulted in a suppression of Id1 expression and an inhibition of proliferation. This effect of rapamycin was reversed by the forced expression of Id1. Rapamycin also prevented the induction of Id2 by lactogenic hormones and milk protein gene expression. Expression of a Id2 transgene bypassed the requirement of mTOR activity for beta-casein induction. These data suggest that mTOR activity has distinguishable functions in the proliferative and the differentiated state of mammary epithelial cells: it is a prerequisite for proliferation through the induction of Id1 and for differentiation-specific gene expression through the induction of Id2. The relative strengths of these proliferation and differentiation signals reflected by the expression levels of the individual Id proteins are crucial to the functional life cycle of mammary epithelial cells and might be disturbed in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772532     DOI: 10.1210/me.2006-0071

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

1.  Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma.

Authors:  Diana M Carvalho; Peter J Richardson; Nagore Olaciregui; Reda Stankunaite; Cinzia Lavarino; Valeria Molinari; Elizabeth A Corley; Daniel P Smith; Ruth Ruddle; Adam Donovan; Akos Pal; Florence I Raynaud; Sara Temelso; Alan Mackay; John P Overington; Anne Phelan; David Sheppard; Andrew Mackinnon; Bassel Zebian; Safa Al-Sarraj; Ashirwad Merve; Jeremy Pryce; Jacques Grill; Michael Hubank; Ofelia Cruz; Andres Morales La Madrid; Sabine Mueller; Angel M Carcaboso; Fernando Carceller; Chris Jones
Journal:  Cancer Discov       Date:  2021-09-22       Impact factor: 39.397

2.  Branched-chain amino acids regulate intracellular protein turnover in porcine mammary epithelial cells.

Authors:  Reza Rezaei; Guoyao Wu
Journal:  Amino Acids       Date:  2022-09-09       Impact factor: 3.789

3.  Intramammary rapamycin administration to calves induces epithelial stem cell self-renewal and latent cell proliferation and milk protein expression.

Authors:  Anna Kosenko; Shamay Jacoby; Tomer-Meir Salame; Maya Ross; Itamar Barash
Journal:  PLoS One       Date:  2022-06-22       Impact factor: 3.752

4.  Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression.

Authors:  Ben A Hall; Tae Yeon Kim; Maxwell N Skor; Suzanne D Conzen
Journal:  Breast Cancer Res Treat       Date:  2012-07-29       Impact factor: 4.872

5.  Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells.

Authors:  Christian R Geest; Fried J Zwartkruis; Edo Vellenga; Paul J Coffer; Miranda Buitenhuis
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

6.  Expression of Id and ITF-2 genes in the mammary gland during pregnancy.

Authors:  Yoko Itahana; Marie Piens; Sylvia Fong; Jarnail Singh; Tomoki Sumida; Pierre-Yves Desprez
Journal:  Biochem Biophys Res Commun       Date:  2008-06-02       Impact factor: 3.575

7.  Associations of the Intellectual Disability Gene MYT1L with Helix-Loop-Helix Gene Expression, Hippocampus Volume and Hippocampus Activation During Memory Retrieval.

Authors:  Agnieszka Kepa; Lourdes Martinez Medina; Susanne Erk; Deepak P Srivastava; Alinda Fernandes; Roberto Toro; Sabine Lévi; Barbara Ruggeri; Cathy Fernandes; Franziska Degenhardt; Stephanie H Witt; Andreas Meyer-Lindenberg; Jean-Christophe Poncer; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Christian P Müller; Andreas Heinz; Henrik Walter; Gunter Schumann; Sylvane Desrivières
Journal:  Neuropsychopharmacology       Date:  2017-05-04       Impact factor: 7.853

8.  Gene networks driving bovine mammary protein synthesis during the lactation cycle.

Authors:  Massimo Bionaz; Juan J Loor
Journal:  Bioinform Biol Insights       Date:  2011-05-04

9.  EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.

Authors:  Traci Galbaugh; Maria Grazia Cerrito; Cynthia C Jose; Mary Lou Cutler
Journal:  BMC Cell Biol       Date:  2006-09-19       Impact factor: 4.241

10.  Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer.

Authors:  Jonathan D Mosley; John T Poirier; Darcie D Seachrist; Melissa D Landis; Ruth A Keri
Journal:  Mol Cancer Ther       Date:  2007-08       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.